RAD51 and Miyoshi myopathy: As revealed in the Fig. 7E-G, MM patients with high expression of these three genes demonstrated a significantly unfavorable overall survival (OS) than patients with low expression (LIG1: probe-set 202726_at, HR = 1.7, P = 0.024; PARP1: probeset 208644_at, HR = 7.6 × 10–5; RAD51: probe-set 205024_s_at, HR = 2.6, P = 2.6 × 10–5).